Equity Analysis

Quarterly Results

    Strides Pharma Science Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    532531
    INE939A01011
    382.4521009
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    STAR
    166.05
    13009.79
    EPS(TTM)
    Face Value()
    Div & Yield %:
    8.52
    10
    0.18
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales609.96585.95617.63
Other Operating Income0.000.000.00
Other Income 23.558.0929.63
Total Income633.50594.04647.27
Total Expenditure 546.94520.19526.92
PBIDT86.5773.86120.35
Interest 50.1548.3846.77
PBDT36.4225.4873.59
Depreciation21.9821.9120.81
Tax-3.021.06-2.83
Fringe Benefit Tax0.000.000.00
Deferred Tax2.150.111.94
Reported Profit After Tax15.312.4053.66
Extra-ordinary Items -0.010.00-0.07
Adjusted Profit After Extra-ordinary item15.322.4053.73
EPS (Unit Curr.)1.660.265.84
EPS (Adj) (Unit Curr.)1.660.265.84
Calculated EPS (Unit Curr.)1.670.265.84
Calculated EPS (Adj) (Unit Curr.)1.670.265.84
Calculated EPS (Ann.) (Unit Curr.)6.661.0523.36
Calculated EPS (Adj) (Ann.) (Unit Curr.)6.661.0523.36
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity91.9091.9091.90
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)14.1912.6119.49
PBDTM(%)5.974.3511.91
PATM(%)2.510.418.69
Dividend Per Share(Rs)0.000.000.00
Diluted EPS1.660.265.83